Loss of plasma membrane integrity, complement response and formation of reactive oxygen species during early myocardial ischemia/reperfusion

Molecular Immunology

Volumn 56, Issue 4, 2013, Pages 507-512

  Charlagorla, Pradeepkumar ^a   Liu, Junying ^a   Patel, Monaliben ^a   Rushbrook, Julie I ^a   Zhang, Ming ^a  

^a Downstate Health Sciences University   (United States)

Author keywords

Catalase; Complement; Inflammation; Loss of plasma membrane integrity (LPMI); Myocardial ischemia; Necrosis; Reactive oxygen species (ROS); Reperfusion injury; SOD1

Indexed keywords

CATALASE; COMPLEMENT COMPONENT C3; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR PARAMETERS; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; GENE OVEREXPRESSION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INFLAMMATION; LOSS OF PLASMA MEMBRANE INTEGRITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; TRANSGENIC MOUSE; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CELL MEMBRANE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; TIME;

ANALYSIS OF VARIANCE; ANIMALS; CATALASE; CELL MEMBRANE; COMPLEMENT C3; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL REPERFUSION INJURY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84881093397     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.05.001     Document Type: Article

References (32)

1. Ambrosio G., Flaherty J.T. Effects of the superoxide radical scavenger superoxide dismutase, and of the hydroxyl radical scavenger mannitol, on reperfusion injury in isolated rabbit hearts. Cardiovascular Drugs and Therapy/Sponsored by the International Society of Cardiovascular Pharmacotherapy 1992, 6:623-632.
2. Birnbaum Y., Hale S.L., Kloner R.A. Differences in reperfusion length following 30minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining. Journal of Molecular and Cellular Cardiology 1997, 29:657-666.
3. Chen X., Mele J., Giese H., Van Remmen H., Dolle M.E., Steinhelper M., Richardson A., Vijg J. A strategy for the ubiquitous overexpression of human catalase and CuZn superoxide dismutase genes in transgenic mice. Mechanisms of Ageing and Development 2003, 124:219-227.
4. Downey J.M., Omar B., Ooiwa H., McCord J. Superoxide dismutase therapy for myocardial ischemia. Free Radical Research Communications 1991, 12-13(Pt 2):703-720.
5. Flaherty J.T., Pitt B., Gruber J.W., Heuser R.R., Rothbaum D.A., Burwell L.R., George B.S., Kereiakes D.J., Deitchman D., Gustafson N., et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 1994, 89:1982-1991.
6. Gallagher K.P., Buda A.J., Pace D., Gerren R.A., Shlafer M. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3hours of occlusion followed by reperfusion. Circulation 1986, 73:1065-1076.
7. Gross G.J., Farber N.E., Hardman H.F., Warltier D.C. Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. American Journal of Physiology 1986, 250:H372-H377.
8. Hangaishi M., Nakajima H., Taguchi J., Igarashi R., Hoshino J., Kurokawa K., Kimura S., Nagai R., Ohno M. Lecithinized Cu, Zn-superoxide dismutase limits the infarct size following ischemia-reperfusion injury in rat hearts in vivo. Biochemical and Biophysical Research Communications 2001, 285:1220-1225.
9. Ito W.D., Schaarschmidt S., Klask R., Hansen S., Schafer H.J., Mathey D., Bhakdi S. Infarct size measurement by triphenyltetrazolium chloride staining versus in vivo injection of propidium iodide. Journal of Molecular and Cellular Cardiology 1997, 29:2169-2175.
10. Jones S.P., Hoffmeyer M.R., Sharp B.R., Ho Y.S., Lefer D.J. Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion. American Journal of Physiology. Heart and Circulatory Physiology 2003, 284:H277-H282.
11. Kanamasa K., Ishida N., Ishikawa K. Protective effect of PEG-SOD against early coronary reperfusion injury assessed in reperfused and non-reperfused ischaemic areas of the same heart. Acta Cardiologica 2001, 56:181-186.
12. Klein H.H., Pich S., Lindert S., Buchwald A., Nebendahl K., Kreuzer H. Intracoronary superoxide dismutase for the treatment of "reperfusion injury", a blind randomized placebo-controlled trial in ischemic, reperfused porcine hearts. Basic Research in Cardiology 1988, 83:141-148.
13. Mates J.M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000, 153:83-104.
14. Matsuda M., Fujiwara H., Kawamura A., Ishida M., Takemura G., Kida M., Uegaito T., Fujiwara Y., Fujiwara T., Kawai C. Failure to reduce infarct size by intracoronary infusion of recombinant human superoxide dismutase at reperfusion in the porcine heart: immunohistochemical and histological analysis. Journal of Molecular and Cellular Cardiology 1991, 23:1287-1296.
15. Murohara Y., Yui Y., Hattori R., Kawai C. Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction. American Journal of Cardiology 1991, 67:765-767.
16. Nejima J., Knight D.R., Fallon J.T., Uemura N., Manders W.T., Canfield D.R., Cohen M.V., Vatner S.F. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 1989, 79:143-153.
17. Nishikawa Y., Yamamoto S., Ataka K., Nakamura K. The effect of superoxide dismutase and catalase on myocardial reperfusion injury in the isolated rat heart. Japanese Journal of Surgery 1991, 21:423-432.
18. Ooiwa H., Stanley A., Felaneous-Bylund A.C., Wilborn W., Downey J.M. Superoxide dismutase conjugated to polyethylene glycol fails to limit myocardial infarct size after 30min ischemia followed by 72h of reperfusion in the rabbit. Journal of Molecular and Cellular Cardiology 1991, 23:119-125.
19. Otani H., Umemoto M., Kagawa K., Nakamura Y., Omoto K., Tanaka K., Sato T., Nonoyama A., Kagawa T. Protection against oxygen-induced reperfusion injury of the isolated canine heart by superoxide dismutase and catalase. Journal of Surgical Research 1986, 41:126-133.
20. Patel B.S., Jeroudi M.O., O'Neill P.G., Roberts R., Bolli R. Effect of human recombinant superoxide dismutase on canine myocardial infarction. American Journal of Physiology 1990, 258:H369-H380.
21. Przyklenk K., Kloner R.A. "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circulation Research 1989, 64:86-96.
22. Richard V.J., Murry C.E., Jennings R.B., Reimer K.A. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90minutes of ischemia in dogs. Circulation 1988, 78:473-480.
23. Shirato C., Miura T., Ooiwa H., Toyofuku T., Wilborn W.H., Downey J.M. Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart. Journal of Molecular and Cellular Cardiology 1989, 21:1187-1193.
24. Uraizee A., Reimer K.A., Murry C.E., Jennings R.B. Failure of superoxide dismutase to limit size of myocardial infarction after 40minutes of ischemia and 4 days of reperfusion in dogs. Circulation 1987, 75:1237-1248.
25. Vakeva A., Morgan B.P., Tikkanen I., Helin K., Laurila P., Meri S. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. American Journal of Pathology 1994, 144:1357-1368.
26. Wang P., Chen H., Qin H., Sankarapandi S., Becher M.W., Wong P.C., Zweier J.L. Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:4556-4560.
27. Watanabe B.I., Premaratne S., Limm W., Mugiishi M.M., McNamara J.J. High- and low-dose superoxide dismutase plus catalase does not reduce myocardial infarct size in a subhuman primate model. American Heart Journal 1993, 126:840-846.
28. Weinbrenner C., Schulze F., Sarvary L., Strasser R.H. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Cardiovascular Research 2004, 61:591-599.
29. Weisman H.F., Bartow T., Leppo M.K., Marsh H.C., Carson G.R., Concino M.F., Boyle M.P., Roux K.H., Weisfeldt M.L., Fearon D.T. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990, 249:146-151.
30. Wessels M.R., Butko P., Ma M., Warren H.B., Lage A.L., Carroll M.C. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:11490-11494.
31. Wolff R.A., Chien G.L., van Winkle D.M. Propidium iodide compares favorably with histology and triphenyl tetrazolium chloride in the assessment of experimentally-induced infarct size. Journal of Molecular and Cellular Cardiology 2000, 32:225-232.
32. Zhang M., Michael L.H., Grosjean S.A., Kelly R.A., Carroll M.C., Entman M.L. The role of natural IgM in myocardial ischemia-reperfusion injury. Journal of Molecular and Cellular Cardiology 2006, 41:62-67.